INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 245 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $334 | -50.7% | 10,576 | -36.3% | 0.03% | -24.3% |
| Q2 2023 | $677 | +40.2% | 16,612 | +19.9% | 0.04% | +76.2% |
| Q1 2023 | $483 | 0.0% | 13,850 | 0.0% | 0.02% | 0.0% |
| Q4 2022 | $483 | -99.9% | 13,850 | +1.1% | 0.02% | -38.2% |
| Q3 2022 | $766,000 | +18.0% | 13,694 | +9.3% | 0.03% | +41.7% |
| Q2 2022 | $649,000 | -11.7% | 12,530 | +23.9% | 0.02% | -4.0% |
| Q1 2022 | $735,000 | -38.6% | 10,111 | -0.1% | 0.02% | -24.2% |
| Q4 2021 | $1,197,000 | -11.7% | 10,124 | +0.3% | 0.03% | -23.3% |
| Q3 2021 | $1,355,000 | -30.7% | 10,098 | -16.3% | 0.04% | -33.8% |
| Q2 2021 | $1,954,000 | +25.7% | 12,067 | -37.7% | 0.06% | +10.2% |
| Q1 2021 | $1,554,000 | +27.5% | 19,363 | -13.6% | 0.06% | +18.0% |
| Q4 2020 | $1,219,000 | +180.2% | 22,409 | +2.3% | 0.05% | +150.0% |
| Q3 2020 | $435,000 | +71.3% | 21,896 | +81.4% | 0.02% | +53.8% |
| Q2 2020 | $254,000 | – | 12,072 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |